Logo

American Heart Association

  50
  0


Final ID: TU237

Behavioral and Medication Adherence Versus Clinical Outcome Among Patients With Cardiovascular Diseases in Ghana

Abstract Body: Background: Africa bears a disproportionate share of the cardiovascular diseases global burden. Despite numerous guidelines in Ghana to enhance cardiovascular health, non-adherence to both lifestyle modification and medication remains prevalent. Combined adherence assessment on medication and lifestyle is crucial to model interventions that address the rising burden of cardiovascular diseases.
Methods: We used a cross-sectional design to assess and quantify lifestyle and medication adherence among 419 patients with cardiovascular diseases at Cape Coast Teaching Hospital in Ghana. We used descriptive analysis to quantify adherence levels and multivariate logistic regression analysis to infer associations and predictors of adherence, uncontrolled hypertension and high blood glucose.
Result: Among 419 participants (mean age = 60 ± 12.3 years), 71.6% adhered to medication (95% CI: 67.0–75.8). Despite high rates of healthy behaviors, non-smoking (98.8%), environmental coping (80%), alcohol abstinence (70%), physical activity (66.8%), and balanced diet (65.2%), only 28.4% limited salt intake. Clinical control was suboptimal, with just 8.3% achieving normal fasting blood glucose and 5.5% having controlled blood pressure. Comorbidity was associated with lower odds of medication adherence (OR = 0.54, 95% CI: 0.35–0.85, p = .007) and normal fasting glucose (OR = 0.45, 95% CI: 0.21–0.99, p = .047). Increasing age was linked to a higher likelihood of uncontrolled blood pressure (OR = 1.75, 95% CI: 1.22–2.51, p = .002).
Conclusion: CVD management needs comprehensive patient-centered care intervention that accounts for optimal adherence to both medications and lifestyle and ensures blood pressure and blood glucose are well controlled among patient with CVD.
  • Gordon, Esther  ( Drexel University , Philadelphia , Pennsylvania , United States )
  • Author Disclosures:
Meeting Info:

EPI-Lifestyle Scientific Sessions 2026

2026

Boston, Massachusetts

Session Info:

Poster Session 1

Tuesday, 03/17/2026 , 05:00PM - 07:00PM

Poster Session

More abstracts on this topic:
From Treatment to Trigger: A Case of Atomoxetine-Induced Brugada Pattern

Abdelsalam Mahmoud, Elsayed Omar, Ezaldin Shady, Ahmed Maram, Gharib Elie

A Model-Sharing Approach for Quality Improvement of Diabetes and Cardiovascular Disease

Elligers Kyle, Pollner Meghan, Overton Katherine, Congdon Michelle, Greenway Stacey, Lambro Patricia, Sadiku Steven, Schechter Rona, Whelan John, Pressley Bianca, Sednew Renee, Duckett Sara

You have to be authorized to contact abstract author. Please, Login
Not Available